Table 2.
Gene | Function | Promoter Methylation | Experimental Model | Reference |
---|---|---|---|---|
P14ARF | Tumor suppressor protein | Hypermethylated | MCPyV-positive/-negative MCC tissues | [115] |
CDKN2A | Tumor suppressor protein | Hypermethylated | MCPyV-positive/-negative MCC tissues | [113] |
RASSF1A | Tumor suppressor protein | Hypermethylated | ||
RASSF2 | Tumor suppressor protein | Hypermethylated | MCPyV-positive/-negative MCC tissues | [116] |
RASSF5C | Tumor suppressor protein | Hypermethylated | ||
RASSF10 | Embryonic neurogenesis | Hypermethylated | ||
RB1 | Tumor suppressor protein | Hypermethylated | MCPyV-positive/-negative MCC tissues | [114] |
MGMT | DNA repair and apoptosis | Hyper-/Hypomethylated | MCPyV-positive MCC cell lines | [117] |
Hypomethylated | MCC tissues * | |||
PTCH1 | HH receptor | Hypomethylated | MCPyV-positive/-negative MCC tissues | [118] |
PD-1 | Immune-inhibitory receptor | Hypomethylated | MCPyV-positive/-negative MCC tissues | [119] |
Multiple genes | Hyper-/Hypomethylated | MCPyV-positive/-negative MCC tissues/cell lines | [120] | |
Multiple genes | Hyper-/Hypomethylated | MCPyV-positive/-negative MCC tissues/cell lines | [121] | |
KDM6B | H3K27 demethylation | Hypomethylated | MCPyV-positive tissues |
* Unknown MCPyV positivity.